FDG-PET shows promise in diagnosing mesothelioma

12/3/2012 | SurvivingMesothelioma.com

A Japanese study published in Experimental and Therapeutic Medicine found that patients with malignant mesothelioma had higher FDG-PET maximum standardized uptake value compared with patients with non-malignant pleural disease. Patients with the highest SUVmax levels also had the lowest chance of long-term survival, according to the study. "Our data suggest that SUVmax levels are useful as an aid for diagnosis and prognosis of malignant pleural mesothelioma," the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ